A Crossover Study to Assess the Relative BA of Delayed-Release Risedronate Compared When Dosed With Either Dinner, Breakfast or Breakfast Plus a Calcium/Vitamin D Tablet.
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2011
At a glance
- Drugs Risedronic acid (Primary)
- Indications Fracture; Male osteoporosis; Osteoporosis; Postmenopausal osteoporosis
- Focus Pharmacokinetics
- Sponsors Procter & Gamble
- 11 Oct 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 24 Mar 2010 Warner Chilcott added as a trial sponsor as reported by ClinicalTrials.gov record.
- 19 Jun 2009 Actual patient number (101) added as reported by ClinicalTrials.gov.